dichlororibofuranosylbenzimidazole has been researched along with Leukemia, Promyelocytic, Acute in 3 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vyginnyĭ, SM | 1 |
| Abramov, EA | 1 |
| Mamaeva, SE | 1 |
| Rasheed, ZA | 1 |
| Saleem, A | 1 |
| Ravee, Y | 1 |
| Pandolfi, PP | 1 |
| Rubin, EH | 1 |
| Kaufmann, SH | 1 |
3 other studies available for dichlororibofuranosylbenzimidazole and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
[The dependence of the quantity of silver granules detectable in interphase nuclei after the silver nitrate staining of the chromosomal nucleolus-organizer regions on the conditions for the hypotonic treatment of the cells and the effect on this index of
Topics: Cells, Cultured; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Fibroblasts; | 1993 |
The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Topics: Amino Acid Sequence; Animals; Binding Sites; Camptothecin; Carrier Proteins; Cell Nucleus; Chromosom | 2002 |
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; | 1991 |